Sunday , May 22 2022

Sue drugs for opioid crisis in the United States



[ad_1]

Florida today filed a lawsuit against the two largest North American drug chain, Valgreens and CVS, as they contributed to the opioid crisis in that southern state and across the country.

The legal claim claims that CVS and Valgreens influenced the rise in the opioid epidemic without taking the necessary measures to stop suspected drugs and prevent illegal sales.

The complaint also alleges that both chains have issued excessive amounts of opioids from their establishments.

According to state prosecutor Pam Bondi, two giant pharmacies joined the existing case against Purdue Pharma, OkiContin's products, and against other manufacturers.

We will continue to persecute companies that have played a role in creating an opioid crisis. Thousands of Floridiana suffered as a result of the Accused's actions, Bondi said in a statement.

According to the lawsuit, Valgreens distributed 2.2 million opioid tablets in his Hadson town, a town of 12,000 inhabitants of Tampa, while in an unidentified city of three thousand people sold 285 thousand pills a month

In the case of CVS, the complaint is believed to have traded 700 million opioid doses from 2006 to 2014, including large sales in Hudson and two other nearby cities.

Through a statement sent to the digital portal The Hill, this other company, regardless of the request, has been drafted, saying it is committed to "the highest standards of ethics and business practices, including compliance with all federal and state laws governing the separation of prescriptions for controlled substances" .

According to CVS, it is committed to reducing abuse and redirecting prescription drugs and has strict policies, procedures and tools for its pharmacists to exercise professional responsibility for assessing the regulations of controlled substances before their release.

High consumption of opiates in the country was a topic that was followed by Donald Trump's administration, which last year declared a national state health crisis as a result of that crisis, which in 2017 led to almost 48,000 deaths.

On October 24, Trump signed a bilateral law aimed at containing this phenomenon and preventing the entry into the power of powerful drugs such as fentanyl, synthetic opioid.

Legislation aims to reduce access to these products; open possibilities for prevention, treatment and recovery of addicts; the fight against illegal opiates; and favored the treatment of opioid-free treatment.

[ad_2]
Source link